CompletedPhase 3

Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury

Egypt88 participantsStarted 2023-06-01

Plain-language summary

This study aims to examine the effects of nebulized heparin on the clinical outcomes in adult patients suffering smoke inhalation injury. Patients will be randomized to receive nebulized heparin or an equal volume of normal saline for 14 days and the incidence of acute lung injury will be compared in either group.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Burn injury \> 24 hours.
✕. History of pulmonary diseases.
✕. Pregnancy or breast feeding.
✕. History of allergy to heparin or HIT.
✕. History or laboratory evidence of coagulopathy.
✕. Burns area \> 50% of total body surface area. -

What they're measuring

VFDs

Timeframe: 28 days

Trial details

NCT IDNCT05886998

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-03

View on ClinicalTrials.gov More Smoke Inhalation Injury trials